S&P 500 cuts losses as Nvidia climbs ahead of results
CAMBRIDGE, Mass.—Quinn Anthony G., a director at Generation Bio Co. (NASDAQ:GBIO), recently made significant purchases of the company's stock, according to a recent SEC filing. On January 10 and January 13, Anthony acquired a total of 210,791 shares of common stock, with transactions totaling approximately $203,209. The shares were acquired at a weighted average price ranging from $0.96 to $0.97 per share, slightly above the current trading price of $0.88. The stock has experienced significant volatility, declining over 66% in the past six months, according to InvestingPro data.
Following these transactions, Anthony's direct ownership in the company increased to 299,286 shares. These purchases reflect a continued interest and investment in the pharmaceutical company's future. Generation Bio Co. is headquartered in Cambridge, Massachusetts, and is focused on developing innovative gene therapies. While the company maintains a strong liquidity position with a current ratio of 6.34, InvestingPro analysis reveals both challenges and opportunities, with 12+ additional exclusive insights available to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.